A plant-based transient expression system for the rapid production of highly immunogenic Hepatitis E virus-like particles
- 1 September 2020
- journal article
- research article
- Published by Springer Nature in Biotechnology Letters
- Vol. 42 (11) , 2441-2446
Abstract
Objective Hepatitis E virus (HEV) infection is a major cause of acute hepatitis worldwide. The aim of the study is the development of plant expression system for the production of virus-like particles formed by HEV capsid and the characterization of their immunogenicity. Results Open reading frame (ORF) 2 encodes the viral capsid protein and possesses candidate for vaccine production. In this study, we used truncated genotype 3 HEV ORF 2 consisting of aa residues 110 to 610. The recombinant protein was expressed in Nicotiana benthamiana plants using the self-replicating potato virus X-based vector pEff up to 10% of the soluble protein fraction. The yield of HEV 110-610 after purification was 150–200 µg per 1 g of green leaf biomass. The recombinant protein formed nanosized virus-like particles. The immunization of mice with plant-produced HEV 110-610 protein induced high levels of HEV-specific serum antibodies. Conclusions HEV ORF 2 (110-610 aa) can be used as candidate for the development of a plant-produced vaccine against Hepatitis E.Keywords
Funding Information
- Российский Фонд Фундаментальных Исследований (18‐54‐18005)
- Bulgarian National Science Fund (DNTC/Russia 02-6)
- Horizon 2020 Framework Programme (739582)
This publication has 19 references indexed in Scilit:
- Hepatitis EGastroenterology Clinics of North America, 2020
- Hepatitis E, what’s the real issue?Liver International, 2020
- Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological EvaluationViruses, 2020
- Development of new hepatitis E vaccinesHuman Vaccines & Immunotherapeutics, 2018
- A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccineVaccine, 2017
- Plant-produced biopharmaceuticals: A case of technical developments driving clinical deploymentScience, 2016
- Update on hepatitis E virology: Implications for clinical practiceJournal of Hepatology, 2016
- Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assayJournal of General Virology, 2006
- Essential Elements of the Capsid Protein for Self-Assembly into Empty Virus-Like Particles of Hepatitis E VirusJournal of Virology, 2005
- Aetiological Agent of Enterically Transmitted Non-A, Non-B HepatitisJournal of General Virology, 1988